• 1. Evolving better nanoparticles: Genetic algorithms for optimising cluster geometries
  Dalton Trans., 2003, 4193-4207
• 2. Evolution study of photo-synthesized gold nanoparticles by spectral deconvolution model: a quantitative approach
  Chung-Sung Yang,Mong-Shian Shih,Fang-Yi Chang New J. Chem., 2006,30, 729-735
• 3. Excimer–monomer switch: a reaction-based approach for selective detection of fluoride?
  Qiao Song,Angela Bamesberger,Lingyun Yang,Haley Houtwed,Haishi Cao Analyst, 2014,139, 3588-3592
• 4. Excitation energies from ground-state density-functionals by means of generator coordinates
  A. B. F. da Silva,K. Capelle Phys. Chem. Chem. Phys., 2009,11, 4564-4569
• 5. Evidence of pre-micellar aggregates in aqueous solution of amphiphilic PDMS–PEO block copolymer?
  Domenico Lombardo,Gianmarco Munaò,Pietro Calandra,Luigi Pasqua,Maria Teresa Caccamo Phys. Chem. Chem. Phys., 2019,21, 11983-11991

Introduction to 3-Chloroquinolin-7-ol (CAS No. 1261598-11-1)

3-Chloroquinolin-7-ol, with the chemical identifier CAS No. 1261598-11-1, is a significant compound in the realm of pharmaceutical chemistry and bioorganic synthesis. This heterocyclic aromatic molecule, featuring a chlorine substituent at the 3-position and a hydroxyl group at the 7-position of the quinoline backbone, has garnered considerable attention due to its versatile structural framework and potential pharmacological applications. The unique combination of these functional groups imparts distinct reactivity, making it a valuable intermediate in the development of novel therapeutic agents.

The quinoline scaffold is well-documented for its broad spectrum of biological activities, including antimicrobial, antimalarial, and anticancer properties. The introduction of a chlorine atom at the 3-position enhances electrophilicity, facilitating further functionalization through nucleophilic aromatic substitution or metal-catalyzed cross-coupling reactions. Concurrently, the hydroxyl group at the 7-position introduces polarity and potential hydrogen bonding capabilities, which can be exploited in drug design to improve solubility and binding affinity.

In recent years, 3-Chloroquinolin-7-ol has been explored as a key precursor in synthesizing quinoline derivatives with enhanced pharmacological profiles. Researchers have leveraged its structural flexibility to develop compounds targeting various diseases. For instance, modifications at the 3- and 7-positions have been strategically employed to modulate interactions with biological targets such as kinases and transcription factors. This adaptability has positioned 3-Chloroquinolin-7-ol as a cornerstone in medicinal chemistry campaigns aimed at discovering next-generation therapeutics.

One notable area of investigation involves the use of 3-Chloroquinolin-7-ol in anticancer drug development. Quinoline derivatives have shown promise in inhibiting tyrosine kinases, which are aberrantly activated in many cancers. The chlorine substituent at the 3-position allows for facile introduction of other pharmacophores that can enhance binding to these kinases. Additionally, computational studies have highlighted that the hydroxyl group at the 7-position can engage in critical hydrogen bonding interactions with residues in the active site of target enzymes, thereby improving drug efficacy.

Another emerging application lies in the synthesis of 3-Chloroquinolin-7-ol derivatives with antimicrobial properties. Given the rise of antibiotic-resistant pathogens, there is an urgent need for novel antimicrobial agents. The quinoline core has demonstrated efficacy against Gram-negative bacteria by disrupting outer membrane integrity. Researchers have synthesized analogs of 3-Chloroquinolin-7-ol that incorporate additional functionalities to broaden their spectrum of activity against multidrug-resistant strains. Preliminary results indicate promising results in vitro, warranting further exploration.

The synthetic pathways to 3-Chloroquinolin-7-ol are also of great interest due to their potential scalability and sustainability. Modern synthetic methods emphasize green chemistry principles, minimizing waste and hazardous reagents. One such approach involves catalytic chlorination followed by selective hydroxylation using environmentally benign conditions. These advancements not only enhance efficiency but also align with global efforts to promote sustainable pharmaceutical manufacturing.

From a biochemical perspective, 3-Chloroquinolin-7-ol serves as a valuable tool for studying enzyme mechanisms and ligand-receptor interactions. Its structural features allow it to mimic natural substrates or inhibitors, providing insights into metabolic pathways and disease mechanisms. This has been particularly useful in understanding how quinoline derivatives interact with cytochrome P450 enzymes, which play a crucial role in drug metabolism.

The future prospects for 3-Chloroquinolin-7-ol are vast and multifaceted. Ongoing research aims to expand its utility in drug discovery by exploring novel synthetic strategies and pharmacological targets. Collaborative efforts between academia and industry are expected to accelerate the development of 3-Chloroquinolin-7-ol based therapeutics, addressing unmet medical needs across various therapeutic areas.

In conclusion, 3-Chloroquinolin-7-ol (CAS No. 1261598-11-1) represents a compelling compound with significant potential in pharmaceutical chemistry. Its unique structural attributes make it an indispensable building block for developing innovative drugs targeting cancer, infections, and other diseases. As research progresses, we can anticipate further breakthroughs leveraging this versatile molecule, reinforcing its importance in modern medicine.

• 861553-63-1(3-Chloro-6-methoxyquinoline)
• 18119-24-9(8-Chloroquinolin-6-OL)
• 858279-19-3(3-chloro-7-methoxy-quinoline)
• 696612-04-1(3-Chloroquinolin-6-ol)
• 25771-92-0(3,6,8-TRICHLOROQUINOLIN-4-OL)
• 181950-57-2(4-chloroquinolin-7-ol)
• 102878-83-1(3-chloro-8-Quinolinol)
• 1167055-30-2(7-chloro-1h-indol-4-ol)
• 86-99-7(7-chloroquinolin-4(1H)-one)
• 1236162-23-4(3-Chloroquinolin-5-ol)